Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Induction of Stress Signaling In Vitro and Suppression of Gonadotropin Secretion by Free Fatty Acids in Female Mouse Gonadotropes.

Li S, Mbong EF, John DT, Terasaka T, Li D, Lawson MA.

Endocrinology. 2018 Feb 1;159(2):1074-1087. doi: 10.1210/en.2017-00638.

PMID:
29315384
2.

Reactive Oxygen Species Link Gonadotropin-Releasing Hormone Receptor Signaling Cascades in the Gonadotrope.

Terasaka T, Adakama ME, Li S, Kim T, Terasaka E, Li D, Lawson MA.

Front Endocrinol (Lausanne). 2017 Oct 30;8:286. doi: 10.3389/fendo.2017.00286. eCollection 2017.

3.

The Clinical and Hormonal Characteristics of Primary Adrenal Lymphomas: The Necessity of Early Detection of Adrenal Insufficiency.

Harada K, Kimura K, Iwamuro M, Terasaka T, Hanayama Y, Kondo E, Hayashi E, Yoshino T, Otsuka F.

Intern Med. 2017 Sep 1;56(17):2261-2269. doi: 10.2169/internalmedicine.8216-16. Epub 2017 Aug 10.

4.

Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein.

Kimura K, Terasaka T, Iwata N, Katsuyama T, Komatsubara M, Nagao R, Inagaki K, Otsuka F.

J Clin Med. 2017 Jan 5;6(1). pii: E6. doi: 10.3390/jcm6010006.

5.

ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.

Kikuchi A, Suzuki T, Nakazawa T, Iizuka M, Nakayama A, Ozawa T, Kameda M, Shindoh N, Terasaka T, Hirano M, Kuromitsu S.

Cancer Sci. 2017 Feb;108(2):236-242. doi: 10.1111/cas.13124.

6.

ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma.

Futami T, Okada H, Kihara R, Kawase T, Nakayama A, Suzuki T, Kameda M, Shindoh N, Terasaka T, Hirano M, Kuromitsu S.

Mol Cancer Ther. 2017 Jan;16(1):68-75. doi: 10.1158/1535-7163.MCT-16-0188. Epub 2016 Nov 11.

7.

The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease.

Terasaka T, Uchida HA, Umebayashi R, Tsukamoto K, Tanaka K, Kitagawa M, Sugiyama H, Tanioka H, Wada J.

BMC Nephrol. 2016 Sep 5;17(1):122. doi: 10.1186/s12882-016-0344-1.

8.

White Feces Caused by the Administration of a Somatostatin Analogue.

Iwamuro M, Terasaka T, Otsuka F, Okada H.

Intern Med. 2016;55(13):1817. doi: 10.2169/internalmedicine.55.6631. Epub 2016 Jul 1. No abstract available.

9.

[A Case of an Adrenocorticotropic Hormone-Producing Pituitary Adenoma Removed via Electromagnetic-Guided Neuroendoscopy].

Tomita Y, Kurozumi K, Terasaka T, Inagaki K, Otsuka F, Date I.

No Shinkei Geka. 2016 Jun;44(6):473-9. doi: 10.11477/mf.1436203313. Japanese.

PMID:
27270145
10.

Invasive Intrasellar Plasmacytoma Mimicking Pituitary Adenoma.

Terasaka T, Inagaki K, Otsuka F.

Intern Med. 2016;55(11):1501-2. doi: 10.2169/internalmedicine.55.6414. Epub 2016 Jun 1. No abstract available.

11.

BMP-6 modulates somatostatin effects on luteinizing hormone production by gonadrotrope cells.

Toma K, Otsuka F, Oguni K, Terasaka T, Komatsubara M, Tsukamoto-Yamauchi N, Inagaki K, Makino H.

Peptides. 2016 Feb;76:96-101. doi: 10.1016/j.peptides.2016.01.011. Epub 2016 Jan 15.

PMID:
26779985
12.

An Insulinoma Discovered in a Patient with Diffusely Calcified Chronic Pancreatitis.

Terasaka T, Tsukamoto K, Inagaki K, Otsuka F.

Intern Med. 2015;54(21):2785-6. doi: 10.2169/internalmedicine.54.5049. Epub 2015 Nov 1. No abstract available.

13.

Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.

Katsuyama T, Otsuka F, Terasaka T, Inagaki K, Takano-Narazaki M, Matsumoto Y, Sada KE, Makino H.

Peptides. 2015 Nov;73:88-94. doi: 10.1016/j.peptides.2015.09.007. Epub 2015 Sep 26.

PMID:
26409788
14.

Complication of chronic eosinophilic pneumonia in an elderly patient with Sjögren syndrome.

Waseda K, Hagiya H, Hanayama Y, Terasaka T, Kimura K, Tsuzuki T, Hasegawa K, Nada T, Nakamura E, Murakami K, Kondo E, Otsuka F.

Acta Med Okayama. 2015;69(2):123-7.

15.

A paraganglioma in a hypertensive patient with unilateral renal hypoplasia.

Terasaka T, Hagiya H, Kimura K, Nada T, Nakamura E, Hanayama Y, Sugiyama H, Kobayashi Y, Yanai H, Otsuka F.

Acta Med Okayama. 2015;69(2):119-22.

16.

Mutual effects of melatonin and activin on induction of aldosterone production by human adrenocortical cells.

Hara T, Otsuka F, Tsukamoto-Yamauchi N, Inagaki K, Hosoya T, Nakamura E, Terasaka T, Komatsubara M, Makino H.

J Steroid Biochem Mol Biol. 2015 Aug;152:8-15. doi: 10.1016/j.jsbmb.2015.04.012. Epub 2015 Apr 15.

PMID:
25889901
17.

Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin.

Hagiya H, Hasegawa K, Asano K, Terasaka T, Kimura K, Nada T, Nakamura E, Waseda K, Hanayama Y, Otsuka F.

Intern Med. 2015;54(5):525-9. doi: 10.2169/internalmedicine.54.3397. Epub 2015 Jan 15.

18.

Interaction of pituitary hormones and expression of clock genes modulated by bone morphogenetic protein-4 and melatonin.

Tsukamoto-Yamauchi N, Terasaka T, Iwasaki Y, Otsuka F.

Biochem Biophys Res Commun. 2015 Mar 27;459(1):172-7. doi: 10.1016/j.bbrc.2015.02.100. Epub 2015 Feb 26.

PMID:
25727018
19.

Regulatory role of BMP-9 in steroidogenesis by rat ovarian granulosa cells.

Hosoya T, Otsuka F, Nakamura E, Terasaka T, Inagaki K, Tsukamoto-Yamauchi N, Hara T, Toma K, Komatsubara M, Makino H.

J Steroid Biochem Mol Biol. 2015 Mar;147:85-91. doi: 10.1016/j.jsbmb.2014.12.007. Epub 2014 Dec 16.

PMID:
25527306
20.

Fosfomycin for the treatment of prostate infection.

Hagiya H, Ninagawa M, Hasegawa K, Terasaka T, Kimura K, Waseda K, Hanayama Y, Sendo T, Otsuka F.

Intern Med. 2014;53(22):2643-6. Epub 2014 Nov 15.

21.

Aortic vascular graft infection caused by Cardiobacterium valvarum: a case report.

Hagiya H, Kokeguchi S, Ogawa H, Terasaka T, Kimura K, Waseda K, Hanayama Y, Oda K, Mori H, Miyoshi T, Otsuka F.

J Infect Chemother. 2014 Dec;20(12):804-9. doi: 10.1016/j.jiac.2014.07.008. Epub 2014 Sep 19.

PMID:
25242585
22.

Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin.

Hagiya H, Terasaka T, Kimura K, Satou A, Asano K, Waseda K, Hanayama Y, Otsuka F.

Intern Med. 2014;53(18):2159-63. Epub 2014 Sep 15.

23.

Filarial chyluria as a rare cause of urinary retention.

Hagiya H, Terasaka T, Kimura K, Satou A, Asano K, Waseda K, Hanayama Y, Takahashi T, Aoe M, Iio K, Watanabe T, Kondo E, Otsuka F.

Intern Med. 2014;53(17):2001-5. Epub 2014 Sep 1.

24.

Recurrent Stenotrophomonas maltophilia bacteremia after iliac crest bone graft harvest.

Hagiya H, Ogawa H, Ishida T, Terasaka T, Kimura K, Waseda K, Hanayama Y, Horita M, Shimamura Y, Kondo E, Otsuka F.

Intern Med. 2014;53(15):1693-8. Epub 2014 Aug 1.

25.

Melatonin counteracts BMP-6 regulation of steroidogenesis by rat granulosa cells.

Nakamura E, Otsuka F, Terasaka T, Inagaki K, Hosoya T, Tsukamoto-Yamauchi N, Toma K, Makino H.

J Steroid Biochem Mol Biol. 2014 Sep;143:233-9. doi: 10.1016/j.jsbmb.2014.04.003. Epub 2014 Apr 19.

PMID:
24751708
26.

Retroperitoneal bronchogenic cyst: a rare incidentaloma discovered in a juvenile hypertensive patient.

Terasaka T, Otsuka F, Ogura-Ochi K, Miyoshi T, Inagaki K, Kobayashi Y, Nasu Y, Makino H.

Hypertens Res. 2014 Jun;37(6):595-7. doi: 10.1038/hr.2014.38. Epub 2014 Mar 6. No abstract available.

PMID:
24599012
27.

Long-term observation of osteomalacia caused by adefovir-induced Fanconi's syndrome.

Terasaka T, Ueta E, Ebara H, Waseda K, Hanayama Y, Takaki A, Kawabata T, Sugiyama H, Hidani K, Otsuka F.

Acta Med Okayama. 2014;68(1):53-6.

28.

Mutual interaction of kisspeptin, estrogen and bone morphogenetic protein-4 activity in GnRH regulation by GT1-7 cells.

Terasaka T, Otsuka F, Tsukamoto N, Nakamura E, Inagaki K, Toma K, Ogura-Ochi K, Glidewell-Kenney C, Lawson MA, Makino H.

Mol Cell Endocrinol. 2013 Dec 5;381(1-2):8-15. doi: 10.1016/j.mce.2013.07.009. Epub 2013 Jul 20.

29.

Melatonin receptor activation suppresses adrenocorticotropin production via BMP-4 action by pituitary AtT20 cells.

Tsukamoto N, Otsuka F, Ogura-Ochi K, Inagaki K, Nakamura E, Toma K, Terasaka T, Iwasaki Y, Makino H.

Mol Cell Endocrinol. 2013 Aug 15;375(1-2):1-9. doi: 10.1016/j.mce.2013.05.010. Epub 2013 May 20.

PMID:
23701823
30.

Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).

Tasaki M, Kobayashi M, Tenda Y, Tsujimoto S, Nakazato S, Numazaki M, Hirano Y, Matsuda H, Terasaka T, Miyao Y, Shimizu Y, Hirayama Y.

Eur J Pharm Sci. 2013 Jun 14;49(3):434-40. doi: 10.1016/j.ejps.2013.04.017. Epub 2013 Apr 24.

PMID:
23624353
31.

Discovery of novel and potent CRTH2 antagonists.

Ito S, Terasaka T, Zenkoh T, Matsuda H, Hayashida H, Nagata H, Imamura Y, Kobayashi M, Takeuchi M, Ohta M.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1194-7. doi: 10.1016/j.bmcl.2011.11.079. Epub 2011 Nov 28.

PMID:
22178554
32.

Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells.

Tsukamoto N, Otsuka F, Miyoshi T, Inagaki K, Nakamura E, Terasaka T, Takeda M, Ogura T, Iwasaki Y, Makino H.

Mol Cell Endocrinol. 2011 Sep 15;344(1-2):41-50. doi: 10.1016/j.mce.2011.06.016. Epub 2011 Jul 1.

PMID:
21742013
33.

Regulation of GNRH production by estrogen and bone morphogenetic proteins in GT1-7 hypothalamic cells.

Otani H, Otsuka F, Takeda M, Mukai T, Terasaka T, Miyoshi T, Inagaki K, Suzuki J, Ogura T, Lawson MA, Makino H.

J Endocrinol. 2009 Oct;203(1):87-97. doi: 10.1677/JOE-09-0065. Epub 2009 Jul 27.

34.

Primary aldosteronism caused by a unilateral adrenal adenoma accompanied by autonomous cortisol secretion.

Suzuki J, Otsuka F, Inagaki K, Otani H, Miyoshi T, Terasaka T, Ogura T, Omori M, Nasu Y, Makino H.

Hypertens Res. 2007 Apr;30(4):367-73.

PMID:
17541216
35.

Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938.

Kuno M, Seki N, Tsujimoto S, Nakanishi I, Kinoshita T, Nakamura K, Terasaka T, Nishio N, Sato A, Fujii T.

Eur J Pharmacol. 2006 Mar 18;534(1-3):241-9. Epub 2006 Mar 3.

PMID:
16515782
36.

Structural basis of compound recognition by adenosine deaminase.

Kinoshita T, Nakanishi I, Terasaka T, Kuno M, Seki N, Warizaya M, Matsumura H, Inoue T, Takano K, Adachi H, Mori Y, Fujii T.

Biochemistry. 2005 Aug 9;44(31):10562-9.

PMID:
16060665
37.

Rational design of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors: predicting enzyme conformational change and metabolism.

Terasaka T, Tsuji K, Kato T, Nakanishi I, Kinoshita T, Kato Y, Kuno M, Inoue T, Tanaka K, Nakamura K.

J Med Chem. 2005 Jul 28;48(15):4750-3.

PMID:
16033254
38.

Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors.

Terasaka T, Kinoshita T, Kuno M, Seki N, Tanaka K, Nakanishi I.

J Med Chem. 2004 Jul 15;47(15):3730-43.

PMID:
15239652
39.

Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors.

Terasaka T, Okumura H, Tsuji K, Kato T, Nakanishi I, Kinoshita T, Kato Y, Kuno M, Seki N, Naoe Y, Inoue T, Tanaka K, Nakamura K.

J Med Chem. 2004 May 20;47(11):2728-31.

PMID:
15139750
40.

A highly potent non-nucleoside adenosine deaminase inhibitor: efficient drug discovery by intentional lead hybridization.

Terasaka T, Kinoshita T, Kuno M, Nakanishi I.

J Am Chem Soc. 2004 Jan 14;126(1):34-5. Erratum in: J Am Chem Soc. 2004 Jun 2;126(21):6833.

PMID:
14709046
41.

Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors.

Terasaka T, Nakanishi I, Nakamura K, Eikyu Y, Kinoshita T, Nishio N, Sato A, Kuno M, Seki N, Sakane K.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1115-8. Erratum in: Bioorg Med Chem Lett. 2003 Nov 17;13(22):4147.

PMID:
12643924
43.

[Peripheral hemodynamics and cardiac capacity in liver diseases].

Haraoka S, Terasaka T, Minato T.

Saishin Igaku. 1971 Dec;26(12):2419-24. Japanese. No abstract available.

PMID:
5160112
44.

[Electrocardiographic QRS complexes and vectorcardiographic QRS loop].

Haraoka S, Itani A, Terasaka T.

Saishin Igaku. 1970 Apr;25(4):838-44. Review. Japanese. No abstract available.

PMID:
4911925
45.

[On the combined therapy of Candida septicemia using the photosensitive pigment NK91].

TERASAKA T, KANAMASA Y, NISHI T, ONO H.

Chiryo. 1962 Oct;44:1948-50. Japanese. No abstract available.

PMID:
13980632

Supplemental Content

Loading ...
Support Center